1views in the last 30 days
SOCIUM Inc.
#Rare Disease
#Artificial Intelligence
#Drug Discovery
#Oncology
#Unmet Medical Needs
#Orphan
#Biotech
Overview
Socium is AI-driven drug discovery biotech predicts the correlation between drugs and diseases based on gene expression. Our innovative AI platform is capable of finding new additional indications for YOUR compound in clinical phase 2 or 3. Especially orphan disease and intractable diseases including cancers.
In addition, the company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months.
Contact Details
contact@socium.co.jp
Koto-ku, Japan
Founded
2017
Employees
10-20
Categories
Keywords
#Rare Disease
#Artificial Intelligence
#Drug Discovery
#Oncology
#Unmet Medical Needs
#Orphan
#Biotech
Companies teams usually look at after SOCIUM Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.